pillbase.ru

Nimvastid

Active substance: rivastigmine

rivastigmine

Centralised EU authorisationActive

Marketing holder: Krka, d.d., Novo mesto

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 11
  • РИСТИМИН®
    пластырь трансдермальный, 13.3 мг/24 ч (original in Russian, GRLS)
    ЛП-№(004804)-(РГ-RU)
    Общество с ограниченной ответственностью "Эндокринные технологии" (ООО "Эндокринные технологии")
  • Ривастигмин Канон
    капсулы, 1.5 мг (original in Russian, GRLS)
    ЛП-№(003388)-(РГ-RU)
    Закрытое акционерное общество "Канонфарма продакшн" (ЗАО "Канонфарма продакшн")
  • Экселон®
    раствор для приема внутрь, 2 мг/мл, 120 мл (original in Russian, GRLS)
    ЛП-№(012513)-(РГ-RU)
    Новартис Фарма АГ
  • Экселон®
    капсулы, 3 мг (original in Russian, GRLS)
    ЛП-№(012698)-(РГ-RU)
    Новартис Фарма АГ
  • Экселон®
    трансдермальная терапевтическая система, 13.3 мг/24 ч (original in Russian, GRLS)
    ЛП-№(015342)-(РГ-RU)
    Новартис Фарма АГ
All products in this country (11)
US 72
  • Exelon
    PATCH, EXTENDED RELEASE · RIVASTIGMINE 4.6 mg/24h
    66758-142
    Sandoz Inc
  • Exelon
    PATCH, EXTENDED RELEASE · RIVASTIGMINE 13.3 mg/24h
    66758-144
    Sandoz Inc
  • Exelon
    PATCH, EXTENDED RELEASE · RIVASTIGMINE 9.5 mg/24h
    66758-143
    Sandoz Inc
  • RIVASTIGMINE TARTRATE
    CAPSULE · RIVASTIGMINE TARTRATE 1.5 mg/1
    33342-089
    Macleods Pharmaceuticals Limited
  • RIVASTIGMINE TARTRATE
    CAPSULE · RIVASTIGMINE TARTRATE 4.5 mg/1
    33342-091
    Macleods Pharmaceuticals Limited
All products in this country (72)
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-5435-76cc-a758-2626809e2bda,01a120c3-64ae-75ef-a43c-de5c6d7471a3,01a120c3-cde1-77e7-8665-04a13e5d7789,01a120c3-cf04-7e7d-8353-ce122cce50af,01a120c3-ecbf-7ac5-9289-d554db5ebfe5;count=11 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-3e35-710c-9af2-2b1929401d28,01a1208c-5063-720a-a2ac-54ad2530f732,01a1208c-89ff-7b36-a994-d390634609bf,01a1208c-bcf7-76e0-a8c7-3324362827eb,01a1208c-c92a-7868-9414-37eea75f55f5;count=72 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/001029
Registration status
Active
ATC code
N06DA03
Sources
  • product · EMA · EMEA/H/C/001029 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/001029 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/001029 · Verified 2026-10-09